Linking Intestinal Diseases to Colorectal Cancer Progression
Author Information
Author(s): Ji Shiliang, Hu Haoran, Zhu Ruifang, Guo Dongkai, Liu Yujing, Yang Yang, Li Tian, Zou Chen, Jiang Yiguo, Liu Guilai, Wong Chi Chun, Kontos Christos K.
Primary Institution: Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University
Hypothesis
The study investigates the molecular interplay between colorectal cancer and intestinal system diseases.
Conclusion
The study identifies potential biomarkers and therapeutic targets that may improve diagnostic and treatment strategies for colorectal cancer influenced by intestinal diseases.
Supporting Evidence
- 160 shared differentially expressed genes were identified between colorectal cancer and intestinal system diseases.
- Nine key hub proteins linking colorectal cancer and intestinal diseases were revealed.
- Survival analysis demonstrated the prognostic potential of shared genes.
- Immunohistochemistry confirmed differential expression of identified genes in cancer tissues.
Takeaway
This study found that certain gut diseases can make people more likely to get colon cancer, and it identified important genes that could help doctors find and treat these cancers better.
Methodology
The study used bioinformatics and machine learning to analyze 12 datasets, identifying differentially expressed genes and conducting survival analysis.
Potential Biases
The study did not search unpublished literature, which may introduce bias.
Limitations
The study's findings may be limited by the small sample sizes from the datasets and the potential for missing genes associated with diseases.
Participant Demographics
The study analyzed data from various populations, including samples from China, India, and Europe.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website